Table 3. Five-year survival and prognostic factors after lung metastasectomy—important studies.
| Primary tumor | Period (years) | Total no. of patients (no. with R0) | 5-year survival (R0) % | Prognostic factors |
| Malignant melanoma | ||||
| Schuhan 2011 (e23) | 1995–2007 | 30 | 35.1 | |
| Andrews 2006 (e48) | 1988–2005 | (86) | (33) | Number |
| Petersen 2007 (e21) | 1970–2004 | 318 (249) | (21) | Histology, disease-free interval, number, extrathoracic metastases |
| Germ cell tumors | ||||
| Kesler 2011 (15) | 1980–2006 | 431 | 79 | Age, histology of metastases, histology of testicular cancer |
| Besse 2009 (e27) | 1980–2003 | 53 | 94 | |
| Pfannschmidt 2006 (e49) | 1996–2001 | 52 (40) | 75.8 (82.8) | Radicality, tumor markers in serum: AFP, hCG ↑ |
R0, resection status 0; AFP, alpha-fetoprotein; hCG, human chorionic gonadotropin